Phenotypic Age Acceleration (PhenoAgeAccel) for Joint Prediction of Disease Risk, Mortality Risk, Life Expectancy, and Disease-Free Healthspan in Major Chronic Diseases

Clinical trial NCT07595094 · RECRUITING

Trial details

NCT number: NCT07595094
Sponsor: Second Affiliated Hospital of Nanchang University
Status: RECRUITING
Study type: OBSERVATIONAL

Phenotypic Age Acceleration Biological Aging Marker Mortality Risk Prediction Disease Risk Prediction Life Expectancy Disease-Free Healthspan Chinese Population Observational Cohort Study

Start date: 2006-06-01
Primary completion: 2030-06-01
Enrollment: 2000000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.